Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Invasive Breast Cancer After Neoadjuvant Chemotherapy
NCT01088893Phase 2Unknown
- Sponsor
- Organisation for Oncology and Translational Research
- Start
- Nov 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in breast cancer, sponsored by Organisation for Oncology and Translational Research. Status: unknown.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01088893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088893.